Will tremelimumab affect lifespan if used for a long time?

Tremelimumab/Tremelimumab is an immunotherapy targeting CTLA-4 and is used to treat certain types of cancer, such as hepatocellular carcinoma, non-small cell lung cancer, etc. There is no clear answer to the question of whether tremelimumab affects lifespan. Although tremelimumab is a cancer treatment drug, it is not guaranteed to cure cancer.

When patients use tremelimumab to treat cancer, the patient's lifespan depends on many factors, including the type and stage of the cancer, the patient's physical condition and the effectiveness of treatment. Tremelimumab is not suitable for all types of cancer and is currently only approved for certain indications. Therefore, before using tremelimumab, patients need to undergo detailed examination and evaluation to ensure its suitability and safety. The use of tremelimumab may cause some side effects, such as immune-related toxicities. These side effects are usually manageable, and regular monitoring and management during treatment is important. However, the severity of specific side effects and individual tolerance may vary from person to person.

Tremelimumab/Tremelimumab is a new type of cancer immunotherapy drug. It has not yet been launched in China, so it cannot be included in the medical insurance. Domestic patients cannot yet purchase this drug. It is understood that the US version of temsitumumab original drug sold overseas may cost more than more than 3,000 US dollars per box, and the specification is 300mg/50mL (20mg/mL). The price is still relatively expensive. At present, we are not aware of the production and release of generic drugs of temsitumumab. For specific overseas prices and drug details, please consult Yaode Medical Consultants.